Caffeine inhibits cell cycle checkpoints, sensitizes cells to ionizing radiation-induced cell killing and inhibits the protein kinase activity of two cell cycle checkpoint regulators, Ataxia-Telangiectasia mutated (ATM) and ATM-and Rad3-related (ATR). In contrast, caffeine has been reported to have little effect on the protein kinase activity of the DNAdependent protein kinase (DNA-PK), which is essential for the repair of DNA double-strand breaks. Previously, we reported that DNA-PK phosphorylates Thr 21 of the 32 kDa subunit of replication protein A (RPA32) in response to camptothecin. In this report we demonstrate that the camptothecininduced phosphorylation of RPA32 on Thr 21 is inhibited by 2 mM caffeine. In addition, we show that caffeine inhibits immunoprecipitated and puri®ed DNA-PK, as well as DNA-PK in cell extracts, with an IC 50 of 0.2±0.6 mM. Caffeine inhibited DNA-PK activity through a mixed non-competitive mechanism with respect to ATP. In contrast, 10-fold higher concentrations of caffeine were required to inhibit DNA-PK autophosphorylation in vitro and caffeine failed to inhibit DNA-PKcs dependent double-strand break repair in vivo. These data suggest that while DNA-PK does not appear to be the target of caffeineinduced radiosensitization, caffeine cannot be used to differentiate between ATM, ATR and DNA-PK-dependent substrate phosphorylation in vivo.
INTRODUCTION
Various biological stresses activate cell cycle checkpoints, which halt cell cycle progression and allow for either DNA repair or apoptotic pathways to function (1, 2) . Two protein kinases important for cell cycle checkpoint induction after DNA damage are Ataxia-Telangiectasia mutated (ATM) and ATM-and Rad3-related (ATR), both of which belong to the phosphatidyl inositol 3-kinase like serine/threonine protein kinase (PIKK) family (reviewed in 3, 4) . Caffeine inhibits the in vitro protein kinase activity of ATM and ATR, with an IC 50 of 0.2 and 1.1 mM, respectively (5) . Treatment of cells with 1 or 3 mM caffeine is suf®cient to inhibit 50% of either ATMor ATR-dependent substrate phosphorylation (5), respectively, and caffeine inhibits various IR and UV-induced cell cycle checkpoints that are ATM and/or ATR-dependent (reviewed in 6). A recent study has suggested that caffeine inhibits cell cycle checkpoints without inhibiting ATM and/or ATR (7) and precisely how caffeine induces radiation sensitivity remains unclear.
Another member of the PIKK family is catalytic subunit of the DNA-dependent protein kinase (DNA-PKcs), which, together with a heterodimeric regulatory subunit (Ku70/80), forms the DNA-dependent protein kinase holoenzyme, DNA-PK (reviewed in 8). Cells de®cient in any component of DNA-PK are radiosensitive due a defect in the primary DNA doublestrand break (DSB) repair pathway called non-homologous end joining (NHEJ). We have recently shown that autophosphorylation of a cluster of residues on DNA-PKcs is essential for DNA DSB repair in vivo (9) . In addition, numerous reports demonstrate that small molecule inhibitors of DNA-PK protein kinase activity radiosensitize cells (10±12), suggesting that the primary physiological substrate of DNA-PK in response to DNA damage may in fact be DNAPKcs. However, DNA-PK has been reported to retain >50% of its activity in in vitro kinase assays in the presence of caffeine concentrations as high as 10 mM (5) and caffeine has no effect on the rate of IR-induced DSB repair in vivo (13) . It is therefore likely that caffeine radiosensitizes cells through a mechanism other than by inhibition of NHEJ. One possibility is that caffeine acts on the homologous recombination (HR) pathway for repair of DNA DSBs, since HR-defective cells display reduced radiosensitization in the presence of caffeine, where as ATM or DNA-PK (NHEJ)-de®cient cells are radiosensitized by caffeine comparable to wild-type cells (13±15). However, it is certainly possible that caffeine has other effects on DNA damage response pathways.
Recently, using a phosphospeci®c antibody that only recognizes the 32-kDa subunit of replication protein A (RPA32) phosphorylated on Thr 21 , we unambiguously identi®ed Thr 21 of RPA32 as an in vitro phosphorylation site of DNA-PK (16). Treatment of cells with camptothecin (CPT), a topoisomerase I inhibitor, induced RPA32 Thr 21 phosphorylation in a DNA-PK-dependent manner (16). Herein we report that the CPT-induced phosphorylation of RPA32 on Thr 21 is inhibited by caffeine. Furthermore, we demonstrate that DNA-PK substrate phosphorylation is directly inhibited by caffeine in in vitro protein kinase assays, indicating that caffeine cannot be used to differentiate between ATM, ATR and DNA-PK-dependent substrate phosphorylation in cells.
MATERIALS AND METHODS

Cell cultures
Human (ATM-de®cient) lymphoblastoid cells (L3) were grown as described previously (17±19). V3 (DNA-PKcsde®cient) hamster cells and V3 cells complemented with the PRKDC cDNA were grown as previously reported (9) .
Reagents
Caffeine (BDH and Sigma) and pentoxifylline (Sigma) were dissolved in water and stored at ±20°C.
Treatment of cell cultures, Af®-gel blue pulldowns and western immunoblot analysis
Cells were treated with CPT and analyzed for RPA32 Thr 21 phosphorylation as described previously (16). Brie¯y, cells were treated with CPT for 2 h, washed in phosphate buffered saline, lysed in buffer containing Nonidet P-40 and extracts were enriched for RPA using Af®-gel blue resin (Bio-Rad). Samples were eluted off the Af®-gel blue resin using SDS sample buffer, fractionated on SDS polyacrylamide gels and immunoblotted with either a mouse monoclonal antibody to RPA32 (Ab-3, Oncogene) or a phospho-speci®c rabbit polyclonal to RPA32 Thr 21 Cell extract assay for DNA-PK activity V3 (DNA-PKcs-de®cient) hamster cells or V3 cells complemented with the cDNA corresponding to human DNA-PKcs were collected, washed in phosphate buffered saline, and then washed in a hypotonic buffer [LSB: 10 mM HEPES pH 7.2, 25 mM KCl, 10 mM NaCl, 1 mM MgCl 2 , 0.1 mM EDTA, 0.1mM dithiothreitol (DTT), 0.2 mM phenylmethyl sulphonyl uoride, 0.2 mg/ml pepstatin A, 0.2 mg/ml aprotinin, 0.2 mg/ml leupeptin]. Cell pellets were re-suspended in two packed cell volumes of LSB and frozen in liquid nitrogen. Lysates were thawed and adjusted to contain 500 mM NaCl, 10 mM MgCl 2 and 0.5 mM DTT. Samples were centrifuged at 10 000 g for 10 min. Cell extracts (15 mg) were incubated with either the DNA-PK substrate peptide (PESQEAFADLWKK-NH 2 ) or a mock peptide (PESEQAFADLWKK-NH 2 ) in a 20 ml assay containing 10 mM HEPES±HCl pH 7.4, 50 mM NaCl, 10 mM MgCl 2 , 100 mg/ml sonicated calf thymus DNA, 0.4 mM EDTA, 0.1 mM DTT, 250 mM ATP, 2 mCi [g-32 P]ATP and 250 mM of the indicated peptide for 5 min at 30°C. Assays were then processed as described previously (20) . Protein concentrations were determined using the Detergent Compatible (DC) protein assay (Bio-Rad) using BSA as the standard.
Assays using puri®ed DNA-PK DNA-PK subunits (DNA-PKcs and Ku70/80) were puri®ed from HeLa cells as described previously (21) with modi®ca-tions as described elsewhere (22) . The protein kinase activity of puri®ed DNA-PK was determined as described previously (21) . DNA-PK autophosphorylation assays were as described previously (23) . PHAS-I was purchased from Stratagene. Heterotrimeric RPA was expressed and puri®ed from Escherichia coli as described previously (24) .
DNA-PK immunoprecipitation kinase assays
Extracts from human lymphoblastoid (L3) cells were prepared as described previously (16), and 1 mg of extract was incubated with 4 ml of a rabbit polyclonal antibody recognizing DNA-PKcs (DPK-1) for 16 h at 4°C with end over end rotation. Protein A sepharose (PAS) was added, the incubation was continued for 45 min, and then the PAS beads were extensively washed as described previously (16). PAS beads were then resuspended in kinase buffer (10 mM HEPES±HCl pH 7.4, 50 mM NaCl, 10 mM MgCl 2 ) containing 1 mM microcystin-LR, 100 mM ATP, 10 mCi [g-32 P]ATP and 0.5 mg PHAS-I, and then incubated for 10 min at 30°C. Reactions were analyzed using SDS±polyacrylamide gel electrophoresis followed by autoradiography.
Pulsed-®eld gel electrophoresis-based DSB repair assay DNA repair assays were carried out basically as described elsewhere (25, 26) . Brie¯y, cells were harvested and resuspended in serum free media (containing a 2Q concentration of caffeine where required), and then mixed with an equal part of 2% agarose. Agarose plugs (50 ml) were cast containing 1 Q 10 8 cells. Once solidi®ed, plugs were put into 2 ml serum free media with the indicated concentration of caffeine and irradiated with 40 Gy at a dose rate of 3.7 Gy/min using a 137 Cs Gamma Cell Irradiator (Nordion). Plugs were returned to 37°C with 5% CO 2 for the indicated period of time and incubated with lysis buffer (50 mM Tris±HCl pH 8.0, 50 mM EDTA, 50 mM NaCl, 2% N-lauryl sarcosyl, 0.1 mg/ml proteinase K) for 1 h at 4°C followed by 15 h at 50°C. Plugs were then washed in TE buffer (10 mM Tris±HCl pH 8.0, 0.1 mM EDTA) and incubated in TE buffer containing 0.1 mg/ml bovine pancreas RNase I A (Roche). Plugs were inserted into wells of a 0.5% agarose gel containing 0.5 mg/ml ethidium bromide and were subjected to pulsed-®eld gel electrophoresis using a CHEF-DRIII (Bio-Rad) apparatus at 2 V/cm for 22 h with a switch time of 1.8 s. Gels were visualized using a Gel Doc 2000 system (Bio-Rad), images were captured and saved in TIFF format using Quantity One software version 4.0.4 (1998), and ethidium bromide staining bands were quantitated using Image Quant (version 5.2). The percent of DSBs unrepaired were estimated as follows:
where, A = DNA migrating into the gel, B = DNA retained within the plug, A o = DNA migrating into the gel when no repair was allowed and B o = DNA retained within the plug when no repair was allowed.
RESULTS
Caffeine inhibits CPT-induced RPA32 Thr 21 phosphorylation
Previously, we con®rmed reports that Thr 21 was the major in vitro phosphorylation site of DNA-PK within RPA32 and, using a phospho-speci®c antibody, demonstrated that this site is phosphorylated in a DNA-PK-dependent manner in response to CPT in human cells (16). In order to con®rm this ®nding, human lymphoblastoid L3 cells (which express DNA-PKcs but lack ATM) were treated with 1 mM CPT, with or without pretreatment with various concentrations of caffeine or wortmannin. As expected (27) , wortmannin concentrations as low as 20 mM inhibited the CPT-induced phosphorylation of RPA32 on Thr 21 (Fig. 1) . However, caffeine concentrations as low as 2 mM were also found inhibit CPT-induced phosphorylation of RPA32 on Thr 21 ( Fig. 1) . Inhibition of CPT-induced RPA32 phosphorylation by caffeine was also observed in experiments where cells were labeled with 32 P-labeled orthophosphate, treated with CPT and analyzed for RPA32 phosphorylation by autoradiography of immunoprecipitated RPA32 (data not shown). These results were unexpected given that a previous report indicated that >10 mM caffeine was required to inhibit 50% of the protein kinase activity of immunoprecipitated DNA-PK (5).
DNA-PK protein kinase activity in cell extracts is inhibited by caffeine
In order to further investigate the effect of caffeine on DNA-PK protein kinase activity, cell extracts from either DNAPKcs-de®cient (V3) hamster cells or V3 cells complemented with the PRKDC cDNA (encoding human DNA-PKcs) were analyzed for DNA-PK activity using either a DNA-PK substrate (SQE) peptide or a mock substrate (SEQ) peptide. Only the PRKDC-complemented V3 cell extracts showed DNA-PK kinase activity, as judged by the difference between phosphorylation of the SQE and SEQ peptides (Fig. 2) . In addition, phosphorylation of the SQE peptide in the PRKDCcomplemented V3 cell extracts was inhibited by both 1 mM wortmannin and 10 mM caffeine (Fig. 2) . The IC 50 for the inhibition of DNA-PK activity in cell extracts by caffeine was determined to be 0.6 mM (as judged by phosphorylation of the SQE peptide with extracts from PRKDC-complemented V3 cells in the presence of increasing concentrations of caffeine, Fig. 3A) . Thus, caffeine appears to potently inhibit the in vitro protein kinase activity of DNA-PK.
Direct inhibition of in vitro DNA-PK substrate phosphorylation by caffeine
Since it was possible that another caffeine-inhibitable protein kinase was contributing to the detected DNA-PK activity in cell extracts, we next determined whether caffeine directly inhibited the protein kinase activity of DNA-PK. Highly puri®ed DNA-PK was used to phosphorylate heterotrimeric RPA (tRPA) in the presence of increasing concentrations of caffeine. Similar to results in cell extracts, the IC 50 for the inhibition of DNA-PK kinase activity was found to be 0.6 mM (Fig. 3B) . Western blots con®rmed that no ATM was present in the puri®ed DNA-PK preparations (data not shown), and the absence of manganese [which is essential for in vitro substrate phosphorylation by ATM and ATR (28±30)] in the kinase assays, provides further evidence that neither ATM nor ATR contributed to the observed kinase activity.
To eliminate the possibility that the inhibition of DNA-PK by caffeine was substrate-dependent, the SQE peptide and PHAS-I were used as substrates in kinase assays using highly puri®ed DNA-PK in the presence of increasing concentrations of caffeine. Caffeine was found to inhibit DNA-PK protein kinase activity towards the SQE peptide and PHAS-I with an IC 50 of 0.2 and 0.3 mM, respectively (Fig. 3C ). In addition, we sought to rule out the possibility that the immunoprecipitation of DNA-PKcs may alter the ability of caffeine to inhibit DNA-PK activity, so DNA-PKcs was immunoprecipitated from ATM-de®cient (L3) cell extracts using a rabbit polyclonal antibody (DPK-1) and used to phosphorylate PHAS-I in the presence of increasing concentrations of caffeine. Once again, caffeine inhibited DNA-PK kinase activity with an IC 50 of 0.6 mM (Fig. 3D) . Similar results were obtained when DNA-PK was immunoprecipitated using a monoclonal antibody that recognizes DNA-PKcs (monoclonal antibody 42±27) (data not shown). Lastly, another methylxanthine, pentoxifylline, was determined to inhibit DNA-PK activity towards the SQE peptide with an IC 50 of 0.2 mM and caffeine purchased from a second supplier inhibited DNA-PK as previously determined (Fig. 3E) .
In order to understand the mechanism of DNA-PK inhibition by caffeine, DNA-PK activity was determined in the presence of various ATP concentrations at various caffeine concentrations. DNA-PK activity was recorded as the picomoles of phosphate incorporated into the SQE substrate peptide per minute, and values of DNA-PK activity and DNA-PK activity divided by the concentration of ATP were plotted on an Eadie-Hofstee graph (Fig. 4) . As the concentration of caffeine increased, the slope (equal to K m ) increased and the y-intercept (equal to V max ) decreased (Table 1) , which is characteristic of mixed non-competitive inhibition of DNA-PK with respect to ATP.
Caffeine has no effect on DNA-PKcs autophosphorylation
The inhibition of DNA-PK by caffeine was dif®cult to reconcile with previous reports stating the DNA-PK-pro®cient and de®cient cells were equally radiosensitized by caffeine and that caffeine has no effect on the rate of IR-induced DSB repair, as well as our own ®ndings that DNA-PKcs autophosphorylation is required for cell survival after ionizing radiation. To address this issue we used the FAR assay to examine the rates of IR-induced DSB repair in cells treated with or without caffeine. As previously reported (13), we did not observe caffeine-induced inhibition of DSB repair (Fig. 5A) . Interestingly, when we assayed for the ability of caffeine to inhibit DNA-PKcs autophosphorylation, 10 times more caffeine was required to inhibit DNA-PKcs autophosphorylation than DNA-PK substrate phosphorylation (Fig. 5B) . Even in the presence of 10 mM caffeine DNA-PK still readily underwent autophosphorylation (25% as compared to no caffeine). Together, these data suggest that inhibition of DNA-PK autophosphorylation likely does not contribute to caffeine induced radiosensitization.
DISCUSSION
In contrast to a previous report (5), we provide evidence that caffeine is an ef®cient inhibitor of the in vitro protein kinase activity of DNA-PK, regardless of whether DNA-PK activity Samples were fractionated on SDS±polyacrylamide gels and RPA32 was excised from the gel and 32 P was quantitated by Cerenkov counting. Assays were done in triplicate and averaged. Error bars are T 1 standard error of the mean (SEM). (C) Highly puri®ed DNA-PK was assayed towards either the DNA-PK substrate peptide or PHAS-I in the presence of increasing concentrations of caffeine. Assays were done in triplicate and averaged. (D) DNA-PKcs was immunoprecipitated from L3 cells using a rabbit polyclonal DNA-PKcs antibody (DPK-1) and assayed for activity towards PHAS-I in the presence of increasing concentrations of caffeine. Assays were done in duplicate and averaged. (E) Highly puri®ed DNA-PK was assayed towards the DNA-PK substrate peptide in the presence of increasing concentration of caffeine (second supplier) and pentoxifylline.
was assayed in whole cell extracts, in immunoprecipitates from whole cell extracts, or using highly puri®ed reconstituted holoenzyme. Furthermore, caffeine inhibited DNA-PKdependent substrate phosphorylation in tissue culture cells. The IC 50 for caffeine inhibition of DNA-PK was intermediate to the values reported for the inhibition of immunoprecipitated or puri®ed ATM (5, 22) and ATR (5), indicating that treatment of cells with caffeine cannot be used to differentiate between the potentially overlapping roles of DNA-PK, ATM and ATR in the regulation of a given substrate phosphorylation event.
Furthermore, caffeine inhibits DNA-PK through a mixed non-competitive mechanism with respect to ATP, which means that caffeine can bind to both DNA-PK and DNA-PK± ATP complexes but with unequal af®nity. We can exclude the possibility that caffeine acts as an ATP-competitive inhibitor based on the decrease in V max observed at increasing caffeine concentrations, and we can exclude uncompetitive inhibition as a possible mode of action based on the changing V max /K m ratio as the concentration of caffeine was increased (Table 1) . Thus caffeine appears to inhibit DNA-PK through binding to a site outside of the ATP-binding pocket located within the active site. Two other well-characterized compounds inhibit DNA-PK through different mechanisms; LY294002 inhibits by directly competing with ATP for the ATP-binding site yielding competitive reaction kinetics; wortmannin inhibits by competing with ATP for the ATP-binding site but also by covalently binding to a key lysine residue within the active site to yield classic non-competitive reaction kinetics (31) . Thus caffeine appears to inhibit DNA-PK kinase activity through a novel mechanism.
We have also shown that DNA-PK autophosphorylation is only weakly inhibited by caffeine in vitro (Fig. 5B) , which likely explains why caffeine has no detectable effect on the rate of DSB repair in vivo (Fig. 5A and 13) . Previously, similar results were described for the inhibition ATM protein kinase activity by caffeine, wherein 1 mM caffeine was suf®cient to nearly abolish immunoprecipitated ATM protein kinase activity towards a GST-p53 substrate but caffeine concentrations as high as 4 mM failed to effect ATM autophosphorylation-dependent activation in vitro (18) . ATM was recently reported to exist as a homodimer in resting cells and DNA damage-induced ATM autophosphorylation on Ser 1981 was associated with ATM monomerization (32) . In addition, two Ku and two DNA-PKcs molecules (a dimer of holoenzymes) are hypothesized to be present at the broken/free DNA ends to facilitate their synapses (in vitro or in vivo), after which DNA-PK autophosphorylation remodels the DNA-PK complex, possibly dissociating DNAPKcs from Ku (8,33±35) . Perhaps the decreased ability of caffeine to inhibit ATM and DNA-PK autophosphorylation relative to substrate phosphorylation re¯ects a homodimerinduced change in the inhibitory caffeine binding site when one molecule of the dimer is positioned in the other's substrate binding (or active) site but not when an exogenous substrate occupies the substrate binding site. It will be interesting to determine whether caffeine has similar effects on other PIKKs, such as ATR and mTOR. 
